Clinical Trials

Find a Trial

Trial Summary

Protocol No.PHO-CROOP-COG-ADVL1515
StatusOPEN TO ACCRUAL
Principal InvestigatorCroop, James
ScopeNational
PhasePhase I
Age GroupChildren
TitleADVL1515, A Phase 1 Study of LY2606368, a CHK1/2 Inhibitor, in Pediatric Patients with Recurrent or Refractory Solid Tumors, including CNS Tumors
Description
Key Eligibility
Applicable Disease SitesAny Site
Unknown Sites
Participating InstitutionsIndiana University (IU)
  • Riley Hospital for Children
Treatment TypeTreatment
ContactMelissa Lee, Phone: +1 317-944-4281
Pager: 312-1228
Email: mellee@iu.edu